2022 - Cardiosafety Testing Based on CiPA - at Scale with SyncroPatch 384 and Genedata Screener
SyncroPatch 384 poster, SLAS 2022 
(1.3 MB)
Abstract:
The direct interaction between the SyncroPatch 384 instrument and Genedata Screener enables seamless, rigorous analysis of hERG, Nav1.5, and other CiPA-mandated ion channel assays in an automated workflow. It makes it easier to consistently apply CiPA guidelines to large-scale, early discovery screens and incorporate them as part of standard operating procedure, including full data traceability and reporting.
Back to Overview